Drug Manufacturers, Therapy Area

Custom Purification of Injectable Polymers via Carbon Dioxide Dissolution

By PIERRE FABRE CDMO Supercritical Fluids

Pierre Fabre Médicament's Supercritical division has devised a smart, good manufacturing practice (GMP) compliant and industrialised process to extract monomers from injectable polymer substances. This innovative process fits with need of biotech / pharmaceutical companies looking for an injectable polymer with a dramatically low impurities content because of a very high dosage of polymer in formulation or an interaction with a reactive active pharmaceutical ingredient (API). The process involves the dissolution of dense carbon dioxide (around 200bar) into a polymer until its saturation. Because of the swelling of polymer chain in dense CO₂, the level of purification is very high leading to a complete extraction of monomers. Download our free white paper for more information.

Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.